Drug Channels 09月29日
AI助力生命科学领域患者支持模式创新
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

本文探讨了人工智能(AI)如何帮助生命科学组织超越碎片化的支持模式,实现更全面和个性化的患者参与。作者提出了三种构建患者支持计划的独特方法,并讨论了AI驱动的工具如何在整个治疗过程中定制干预措施。
Today’s guest post comes from Stacey Little, Chief Growth Officer at AssistRx.

In this guest post, Stacey explores how artificial intelligence (AI) is helping life sciences organizations move beyond fragmented support models to deliver more integrated and personalized patient engagement. She outlines three distinct approaches to structuring patient support programs and discusses how AI-driven tools—such as AllazoHealth—can help tailor interventions across the entire treatment journey.

To learn more, see the AssistRx case study: Sophisticated Patient Engagement Programs that Improve Experiences and Outcomes.

Read on for Stacey’s insights.
Read more »

© 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

人工智能 生命科学 患者支持
相关文章